- Home
- BLRX vs KPLT Comparison
BLRX vs KPLT Comparison
Compare BLRX & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- KPLT
- Stock Information
- Founded
- BLRX 2003
- KPLT 2012
- Country
- BLRX Israel
- KPLT United States
- Employees
- BLRX N/A
- KPLT N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- KPLT Diversified Commercial Services
- Sector
- BLRX Health Care
- KPLT Consumer Discretionary
- Exchange
- BLRX Nasdaq
- KPLT Nasdaq
- Market Cap
- BLRX 54.1M
- KPLT 49.2M
- IPO Year
- BLRX 2011
- KPLT N/A
- Fundamental
- Price
- BLRX $0.46
- KPLT $10.38
- Analyst Decision
- BLRX Strong Buy
- KPLT Hold
- Analyst Count
- BLRX 2
- KPLT 1
- Target Price
- BLRX $11.50
- KPLT $15.00
- AVG Volume (30 Days)
- BLRX 202.4K
- KPLT 23.4K
- Earning Date
- BLRX 11-18-2024
- KPLT 11-06-2024
- Dividend Yield
- BLRX N/A
- KPLT N/A
- EPS Growth
- BLRX N/A
- KPLT N/A
- EPS
- BLRX N/A
- KPLT N/A
- Revenue
- BLRX $17,048,000.00
- KPLT $236,293,000.00
- Revenue This Year
- BLRX N/A
- KPLT $14.79
- Revenue Next Year
- BLRX N/A
- KPLT $12.23
- P/E Ratio
- BLRX N/A
- KPLT N/A
- Revenue Growth
- BLRX N/A
- KPLT 14.82
- 52 Week Low
- BLRX $0.44
- KPLT $8.26
- 52 Week High
- BLRX $1.93
- KPLT $23.54
- Technical
- Relative Strength Index (RSI)
- BLRX 23.64
- KPLT 41.83
- Support Level
- BLRX $0.50
- KPLT $9.99
- Resistance Level
- BLRX $0.56
- KPLT $10.49
- Average True Range (ATR)
- BLRX 0.05
- KPLT 0.69
- MACD
- BLRX -0.01
- KPLT 0.15
- Stochastic Oscillator
- BLRX 10.60
- KPLT 28.33
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc is a technology driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an E-Commerce focused FinTech company offering an innovative lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.